Benzinga | Feb 16, 2021 07:30AM EST

Credit Suisse Maintains Outperform on Medpace Hldgs, Raises Price Target to $178

Credit Suisse analyst Erin Wright maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $155 to $178.